Tracheal Stenosis

Tracheal stenosis is a pathological narrowing of the tracheal lumen caused by neoplastic or nonneoplastic processes, most commonly iatrogenic (post-intubation/post-tracheostomy), but also arising from autoimmune, inflammatory, infectious, or idiopathic etiologies.[1-2] It is frequently misdiagnosed as asthma or COPD due to overlapping symptoms, with a median diagnostic delay of 12 months in inflammatory cases.[3]

1. History

• Onset and progression: Insidious vs. acute; post-intubation stenosis typically presents 4–6 weeks after extubation with delayed dyspnea[4]
• Symptom characterization: Exertional dyspnea (most common), inspiratory stridor, biphasic stridor, wheezing, chronic cough, hoarseness, exercise intolerance[1][5]
• Timing/triggers: Symptoms worsen with exertion, URI, or cold air; may be positional
• Severity: Quantify dyspnea (at rest vs. exertion), ability to perform ADLs, sleep-disordered breathing[6]
• Prior airway instrumentation: Duration of intubation, tracheostomy history, number of intubation attempts, cuff pressures used[7]
• Important negatives: Lack of response to bronchodilators or inhaled corticosteroids (distinguishes from asthma); absence of diffuse wheezing on auscultation[8]

2. Alarm Features

• Stridor at rest — indicates >50% luminal narrowing; critical stenosis typically at >70% obstruction[9-10]
• Acute respiratory distress, cyanosis, inability to lie flat
• Inability to pass suction catheter through tracheostomy[11]
• Rapid progression of dyspnea over hours to days
• Hemoptysis — raises concern for malignant etiology or erosion[5]
• Failed response to bronchodilators/steroids in a patient labeled as asthma — should prompt airway evaluation[8]

3. Medications

• Contributing medications: No specific medications directly cause tracheal stenosis, but prolonged corticosteroid use may impair wound healing; diabetes medications should be optimized as diabetes is a risk factor for stenosis[7]

Treatments

• Intralesional triamcinolone acetonide injection at time of dilation reduces recurrence (37% vs. 54.5% without)[12]
• Topical mitomycin C application — 75% success rate at 4 months vs. 15% for dilation alone[13]
• Post-procedural inhaled budesonide as recurrence prophylaxis[12]
• PPIs (e.g., omeprazole 80 mg/day) for GERD-associated stenosis[4][14]
• Systemic immunosuppression (glucocorticoids ± methotrexate) for GPA- or RP-related stenosis[3]
• Contraindicated: Avoid heat-based ablative therapies with FiO₂ >0.4 (airway fire risk)[13]

4. Diet

• GERD management: GERD is a recognized risk factor and potential contributor to tracheal stenosis recurrence. Anti-reflux dietary modifications (avoid late meals, acidic/spicy foods, caffeine, alcohol) are recommended as adjunctive therapy[1][4]
• Hydration: Adequate hydration to maintain airway secretion clearance, especially in stented patients
• Weight management: Obesity is associated with iatrogenic tracheal stenosis and may complicate airway management[4][7]

5. Review of Systems

• Pulmonary: Dyspnea, stridor, wheezing, cough, hemoptysis, exercise intolerance
• ENT: Hoarseness, voice changes, dysphagia, globus sensation, nasal crusting/epistaxis (GPA)
• GI: Heartburn, regurgitation, chronic throat clearing (GERD/LPR)
• Rheumatologic: Joint pain, skin rashes, ear/nose cartilage pain (relapsing polychondritis), sinusitis, renal symptoms (GPA)[3]
• Constitutional: Fevers, weight loss, night sweats (malignancy, vasculitis, TB)

6. Collateral History and Family History

• Collateral: ICU records — duration of intubation, cuff pressures, number of reintubations, tracheostomy details, ventilator settings[7]
• Family history: Generally not hereditary; however, congenital tracheal stenosis exists in pediatric populations[15]
• Social context: Occupational exposures (chemical/thermal inhalation), smoking history (predictor of need for resection), illicit drug use (inhalational injuries)[16]

7. Risk Factors

• Iatrogenic (most common, >80% of acquired cases): Prolonged intubation, tracheostomy, prior airway surgery[7][17]
• Duration of intubation and mechanical ventilation[7]
• Diabetes mellitus — independent risk factor for stenosis development and decannulation failure[4][7]
• Respiratory tract infection during intubation[7]
• High tracheostomy incision[7]
• Cuff-to-trachea diameter ratio (C/T) >150%[7]
• GERD/laryngopharyngeal reflux[1][4]
• Autoimmune diseases: GPA (41%), relapsing polychondritis (26%) among inflammatory causes[3]
• Idiopathic subglottic stenosis: Almost exclusively middle-aged white females[4][18]
• Obesity, vascular disease[4]
• Radiation therapy, infections (TB), sarcoidosis, amyloidosis[1][19]

8. Differential Diagnosis

• Asthma/reactive airway disease — most common misdiagnosis; distinguished by lack of bronchodilator response and fixed obstruction on PFTs[8][20]
• COPD — diffuse lower airway obstruction; coexisting COPD may mask tracheal stenosis on PFTs[5]
• Vocal cord dysfunction (VCD)/paradoxical vocal fold motion — episodic, inspiratory stridor, normal between episodes
• Tracheal/endobronchial malignancy — adenoid cystic carcinoma, squamous cell carcinoma, carcinoid[5][21]
• Tracheobronchomalacia — dynamic collapse rather than fixed stenosis; diagnosed on dynamic expiratory CT[13]
• Extrinsic compression — thyroid goiter, mediastinal mass, vascular ring
• Foreign body aspiration
• Angioedema — acute onset, associated urticaria
• Epiglottitis/croup — infectious, acute presentation

9. Past Medical History

• Prior intubation/tracheostomy (duration, number of episodes)
• Previous airway dilations or surgeries (number and type — critical for treatment planning)[16][22]
• Autoimmune conditions (GPA, relapsing polychondritis, sarcoidosis, Crohn's disease)[3]
• GERD history[4]
• Diabetes mellitus[7]
• Prior radiation therapy to head/neck/chest
• History of inhalational injury or external neck trauma
• Smoking history[16]

10. Physical Exam

• Vital signs: Tachypnea, hypoxia (late finding), use of accessory muscles
• Inspection: Stridor (inspiratory = extrathoracic; biphasic = fixed; expiratory = intrathoracic), tracheal tug, suprasternal/intercostal retractions[15]
• Auscultation: Monophonic wheeze or stridor loudest over the neck/central airways (vs. diffuse polyphonic wheezing in asthma); diminished air entry in severe stenosis
• Neck exam: Tracheostomy site/scar, tracheal deviation, thyroid enlargement, cervical lymphadenopathy
• ENT findings: Saddle nose deformity, nasal crusting (GPA); auricular chondritis, ear/nose tenderness (relapsing polychondritis)[3]
• Concerning findings: Stridor at rest, cyanosis, inability to speak in full sentences, tripod positioning

11. Lab Studies

• Baseline: CBC, BMP, coagulation studies (preoperative)

Autoimmune workup (when inflammatory etiology suspected)

• ANCA (c-ANCA/PR3 for GPA)[3][23]
• ESR, CRP
• ANA, anti-dsDNA (if lupus suspected)
• Infectious: AFB cultures, fungal cultures (if TB or fungal etiology suspected)
• GERD evaluation: Consider 24-hour pH monitoring or impedance testing[4][14]
• Biopsy at bronchoscopy: Histopathology to distinguish granulomatous, fibrotic, or malignant processes[1][24]

12. Imaging

• First-line: CT chest (with or without IV contrast) — the ACR Appropriateness Criteria rates CT as the initial imaging modality of choice for suspected tracheal stenosis. CT with IV contrast is preferred when malignancy or mediastinal pathology is suspected[21]
• Multiplanar reconstructions (MPR) and virtual bronchoscopy are helpful adjuncts for preprocedural planning[21]
• 3D volume rendering accurately predicts stenosis location, length, and severity[21]
• Dynamic expiratory CT: Useful to evaluate for concurrent tracheomalacia[21]
• Chest X-ray: May show tracheal narrowing; the "inverted steeple sign" has been described for lower tracheal stenosis; generally insufficient for definitive diagnosis[15]
• MRI: Limited role; a meta-analysis found critically low specificity (6–46%) for grading stenosis. May be useful for GPA-related SGS monitoring without radiation[25-26]
• Imaging unnecessary: Stable, known mild stenosis under surveillance with PFTs and clinical assessment

13. Special Tests

Myer-Cotton grading system

• Grade I: ≤50% obstruction
• Grade II: 51–70% obstruction
• Grade III: 71–99% obstruction
• Grade IV: No detectable lumen
• Higher grades (and pre-operative tracheostomy) are independent predictors of need for surgical resection[16]

Pulmonary function tests / Flow-volume loops

• Fixed obstruction: Plateau on both inspiratory and expiratory limbs (rectangular loop)
• Variable extrathoracic: Plateau on inspiratory limb with preserved expiratory flow
• Variable intrathoracic: Plateau on expiratory limb with preserved inspiratory flow
• FEV₁/PEF ratio >8 mL·L⁻¹·min⁻¹ suggests central/upper airway obstruction[28]
• Expiratory Disproportion Index (EDI): Highest sensitivity (88%) for predicting need for intervention[30]
• PEF, PIF, and EDI all significantly improve after stenosis is relieved[30]
• Bronchoscopy: Diagnostic gold standard — allows direct visualization, grading, biopsy, and simultaneous therapeutic intervention[1][5][24]

14. ECG

• ECG is not a primary diagnostic tool for tracheal stenosis
• Obtain ECG as part of preoperative assessment before bronchoscopy or surgical intervention
• Chronic hypoxia from severe stenosis may show signs of right heart strain (right axis deviation, P pulmonale, RV hypertrophy) in advanced cases
• Rule out cardiac causes of dyspnea in the differential

15. Assessment

• Clinical summary: Tracheal stenosis presents insidiously with progressive dyspnea, stridor, and exercise intolerance. Symptoms typically do not manifest until >50% luminal narrowing, and work of breathing increases rapidly beyond 70% obstruction[9-10]
• Severity stratification: Based on Myer-Cotton grade, PFT findings, and symptom burden[18][27]
• Typical presentation: Post-intubation — delayed onset 4–6 weeks after extubation; idiopathic SGS — middle-aged white female with progressive dyspnea misdiagnosed as asthma[4][18]
• Atypical presentations: Inflammatory stenosis may present as the first manifestation of systemic disease in 66% of cases[3]
• Complications: Respiratory failure, recurrent pneumonia, mucus plugging (especially with stents), airway fire during procedures, restenosis (76% relapse rate in inflammatory causes)[3][31]

16. Treatment Plan

Initial stabilization (ED)

• Secure airway — heliox (70:30 or 80:20) as temporizing measure to reduce work of breathing
• Humidified oxygen, upright positioning
• Racemic epinephrine nebulization for acute mucosal edema
• Dexamethasone IV for edema reduction
• If critical obstruction: emergent rigid bronchoscopy for debulking/dilation; if unavailable, endotracheal intubation with a smaller tube past the stenosis or emergent tracheostomy/cricothyrotomy[5][11]

Definitive management

• The ACCP 2025 guidelines recommend a comprehensive evaluation including CT chest and appropriate labs, followed by either therapeutic bronchoscopy or surgical resection for symptomatic stenosis:[13]
• Surgical resection with primary anastomosis: Preferred definitive treatment for focal benign stenosis in operable patients. Three-year recurrence rate of only 1.2% vs. 28% for dilation and 12.4% for endoscopic resection with medical therapy. Resection-anastomosis showed adjusted HR 2.0 for clinical resolution compared to stenting[13][32]
• Endoscopic interventions (for non-surgical candidates or as bridge to surgery):
• Balloon or rigid dilation ± adjunctive therapies[13]
• Laser (CO₂, Nd:YAG) or electrocautery ablation of scar tissue[13]
• Intralesional triamcinolone injection[12]
• Topical mitomycin C application[13]
• Airway stent placement — reserved for failed bronchoscopic/systemic treatments[13]
• Rigid bronchoscopy preferred over flexible for therapeutic interventions, under general anesthesia[13]
• Systemic therapy: Glucocorticoids + methotrexate for GPA/RP-related stenosis; anti-GERD therapy for reflux-associated stenosis[3][14]

17. Disposition

• Admission criteria: Stridor at rest, respiratory distress, hypoxia, need for emergent airway intervention, new diagnosis with significant obstruction (Myer-Cotton grade III–IV)
• ICU admission: Impending respiratory failure, post-emergent airway intervention, hemodynamic instability
• Observation: Post-dilation monitoring (typically 4–6 hours minimum), new stent placement
• Discharge criteria: Stable airway, no stridor at rest, adequate oxygenation, able to tolerate oral intake, reliable follow-up arranged
• Specialist consultation triggers: Interventional pulmonology, thoracic surgery, and otolaryngology — a multidisciplinary team approach is essential. Rheumatology for suspected autoimmune etiology[1][3][13]

18. Follow Up / Return Precautions

• Follow-up timing: Post-dilation — 4–6 weeks for reassessment; PFTs at regular intervals for surveillance (PEF is a simple, reliable monitoring parameter)[18][30]
• Symptoms requiring immediate reassessment: Worsening dyspnea, new or worsening stridor, inability to clear secretions, fever (if stented — concern for granulation tissue/infection), hemoptysis

Patient counseling

• Recurrence is common — 76% relapse rate in inflammatory causes; >85% of idiopathic SGS patients require repeat intervention within 5 years[3][18]
• Compliance with anti-reflux therapy if GERD is identified[14]
• Smoking cessation (smoking history predicts need for resection)[16]
• Diabetes optimization[7]
• Expected recovery: Post-dilation — immediate symptom improvement but high recurrence risk; post-surgical resection — excellent long-term outcomes with low recurrence in appropriately selected patients[13][32]

References

1. The Role of Bronchoscopy in the Multidisciplinary Approach to Benign Tracheal Stenosis. — Ravikumar N, Ho E, Wagh A, Murgu S. Journal of Thoracic Disease. 2023.

2. Tracheobronchial Stenosis: Causes and Advances in Management. — Puchalski J, Musani AI. Clinics in Chest Medicine. 2013.

3. Presentation, Diagnosis, and Management of Subglottic and Tracheal Stenosis During Systemic Inflammatory Diseases. — Catano J, Uzunhan Y, Paule R, et al. Chest. 2022.

4. Laryngotracheal stenosis: Mechanistic review. — Carpenter DJ, Hamdi OA, Finberg AM, Daniero JJ. Head & Neck. 2022.

5. Interventional Pulmonology. — Seijo LM, Sterman DH. The New England Journal of Medicine. 2001.

6. Acquired Tracheal Stenosis: Cervical Slide Tracheoplasty. — Li C, Rutter MJ. Seminars in Pediatric Surgery. 2021.

7. Risk Factors for Patients With Tracheal Stenosis: A Systematic Review and Meta-Analysis. — Hong S, Wu X, Feng H, et al. The Journal of International Medical Research. 2024.

8. Management of Postintubation Tracheal Stenosis in a Neurosurgical Patient With Tracheomalacia and Scarring Tendency: A Case Report. — Zhan Y, Zhang S, Chen M, Pu H. Medicine. 2026.

9. Subglottic Stenosis Position Affects Work of Breathing. — Yang MM, Higano NS, Gunatilaka CC, et al. The Laryngoscope. 2021.

10. Relationship Between Degree of Obstruction and Airflow Limitation in Subglottic Stenosis. — Lin EL, Bock JM, Zdanski CJ, Kimbell JS, Garcia GJM. The Laryngoscope. 2018.

11. Successful Rescue Using Tracheal Intubation Cannula for Severe Central Airway Stenosis After Tracheotomy: A CARE Compliant Case Report. — Li HF, Xing BP, Song LS, Wang W, Liu BH. Medicine. 2020.

12. Endoscopic Treatment of Benign Tracheal Stenosis: A Single-Centre Study. — Kather D, Steinack C, Franzen DP. Swiss Medical Weekly. 2024.

13. Management of Central Airway Obstruction: An American College of Chest Physicians Clinical Practice Guideline. — Mahmood K, Frazer-Green L, Gonzalez AV, et al. Chest. 2025.

14. Idiopathic Tracheal Stenosis: Successful Outcome With Antigastroesophageal Reflux Disease Therapy. — Terra RM, de Medeiros IL, Minamoto H, et al. The Annals of Thoracic Surgery. 2008.

15. The Inverted Steeple Sign, Tracheal Tug, and Biphasic Stridor: A Triad for Diagnosing Congenital Tracheal Stenosis. — Rajvanshi N, Ks A, Kumar TVV. Pediatric Pulmonology. 2025.

16. Management of Benign Airway Stenosis-Predictors of Tracheal Resection. — Patel AJ, Budacan AM, Kumar S, et al. Journal of Thoracic Disease. 2024.

17. Staged Laryngotracheoplasty in Adult Laryngotracheal Stenosis: Predictors of Long-term Decannulation. — Liu IY, Mendelsohn AH, Ching H, et al. JAMA Otolaryngology-- Head & Neck Surgery. 2015.

18. Utility of Routine Spirometry Measures for Surveillance of Idiopathic Subglottic Stenosis. — Carpenter DJ, Ferrante S, Bakos SR, et al. JAMA Otolaryngology-- Head & Neck Surgery. 2019.

19. Nonneoplastic Tracheal and Bronchial Stenoses. — Grenier PA, Beigelman-Aubry C, Brillet PY. Radiologic Clinics of North America. 2009.

20. Flow Volume Loops in the Evaluation of Upper Airway Obstruction. — Lunn WW, Sheller JR. Otolaryngologic Clinics of North America. 1995.

21. ACR Appropriateness Criteria® Tracheobronchial Disease. — Expert Panel on Thoracic Imaging, Little BP, Walker CM, et al. Journal of the American College of Radiology : JACR. 2024.

22. Predictors of Response to Endoscopic Management of Subglottic/­Tracheal Stenosis in Patients Without Tracheostomy. — Ahmadian D, Gleadhill CM, Wehbi N, Bixby BA, Yip HT. American Journal of Otolaryngology. 2023.

23. Clinical Manifestations and Treatment of Idiopathic and Wegener Granulomatosis–Associated Subglottic Stenosis. — Taylor SC, Clayburgh DR, Rosenbaum JT, Schindler JS. JAMA Otolaryngology-- Head & Neck Surgery. 2013.

24. A Review on Diagnostic Assessments of Tracheal Stenosis. — Monjezi M, Rismanian M, Jamaati H. Biomedical Engineering Online. 2025.

25. Diagnostic Accuracy of Non-Invasive Modalities for Laryngotracheal Stenosis: A Systematic Review and Meta-Analysis. — Klopper GJ, Adeniyi OV. European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies : Affiliated With the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. 2026.

26. Accuracy of Magnetic Resonance Imaging for Grading of Subglottic Stenosis in Patients With Granulomatosis With Polyangiitis: Correlation With Pulmonary Function Tests and Laryngoscopy. — Henes FO, Laudien M, Linsenhoff L, et al. Arthritis Care & Research. 2018.

27. Endoscopic Management of Subglottic Stenosis. — Feinstein AJ, Goel A, Raghavan G, et al. JAMA Otolaryngology-- Head & Neck Surgery. 2017.

28. ERS/­ATS Technical Standard on Interpretive Strategies for Routine Lung Function Tests. — Stanojevic S, Kaminsky DA, Miller MR, et al. The European Respiratory Journal. 2022.

29. Evaluation of Major Airway Lesions Using the Flow-Volume Loop. — Hyatt RE. The Annals of Otology, Rhinology, and Laryngology. 1975.

30. Spirometry in Laryngotracheal Stenosis: A Systematic Review and Meta-Analysis. — Alshareef W, Almutairi N, Sindi A, et al. European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies : Affiliated With the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. 2023.

31. Treatment of Benign Tracheal Stenosis Using Endoluminal Spray Cryotherapy. — Bhora FY, Ayub A, Forleiter CM, et al. JAMA Otolaryngology-- Head & Neck Surgery. 2016.

32. Stent and Resection Anastomosis in Patients With Complex Tracheal Stenosis: The Stars Retrospective Multicenter Trial. — Marchioni A, Moretti A, Tonelli R, et al. Interdisciplinary Cardiovascular and Thoracic Surgery. 2025.